Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.050
-0.040 (-1.91%)
At close: Aug 1, 2025, 4:00 PM
2.060
+0.010 (0.48%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $4.86 million as of August 1, 2025. Its market cap has increased by 36.88% in one year.
Market Cap
4.86M
Enterprise Value
2.06M
1-Year Change
36.88%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $4.86M, a decrease of -99.99%. That is a compound annual growth rate of -71.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 4.86M | -54.25% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | 18.67B | 21.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.54B |
| Johnson & Johnson | 401.54B |
| AbbVie | 342.79B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 230.41B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 224.07B |
| Novo Nordisk | 221.96B |